跳至主要内容
临床试验/ITMCTR2200006651
ITMCTR2200006651尚未招募1 期

Study on the intestinal mechanism of Jianpi Qushi He Luo Fang in regulating intestinal bacteria AHR agonist host immunity in treating IM

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • (1) Kidney biopsy pathological diagnosis of MN, or positive anti-PLA2R antibody;
  • (2) Meet the diagnostic criteria of spleen deficiency syndrome;
  • (3) The course of disease is longer than 6 months;
  • (4) Urine protein was quantified at 3-8g /24h;
  • (5) Blood pressure can be effectively controlled at =140/90mmHg;
  • (6) eGFR 45 ml/min or more,
  • (7) 18-70 years old, no gender limitation;
  • (8) Antibiotics and probiotics have not been used in the past one month;
  • (9) Body mass index (BMI) between 18.5 and 28.5 kg/m2;
  • (10) Signed informed consent.

排除标准

  • (1) Exclude secondary membranous nephropathy (including tumor-related membranous nephropathy, hepatitis B-related membranous nephropathy, lupus membranous nephropathy, drug and toxin-related membranous nephropathy);
  • (2) the eGFR < 45 ml/min.
  • (3) hormone and/or immunosuppressant treatment within 6 months;
  • (4) women who have pregnancy plan, pregnancy or breast-feeding period;
  • (5) complicated with serious diseases of heart, brain, liver and hematopoietic system, or other serious diseases affecting their survival;
  • (6) Metabolic diseases such as obesity and diabetes;
  • (7) History of gastrointestinal diseases or gastrointestinal surgery (except appendectomy);
  • (8) Rheumatoid arthritis, sjogren's syndrome and other autoimmune diseases;
  • (9) Antibiotics and probiotics were used within the past one month.

研究者

相似试验

Study on the intestinal mechanism of Jianpi Qushi He... | 临床试验